Literature DB >> 7648791

Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus.

L Cominacini1, U Garbin, A M Pastorino, A Fratta Pasini, M Campagnola, A De Santis, A Davoli, V Lo Cascio.   

Abstract

The susceptibility of LDL to copper-catalyzed oxidation was evaluated in 24 patients with insulin-dependent and 16 patients with non-insulin-dependent diabetes mellitus, 14 abdominal and 14 gluteal-femoral obese women, 22 familial hypertriglyceridemic and 28 control subjects. Differences in the LDL susceptibilities were studied by measuring the changes of fluorescence intensity and expressed as lag-phase. The lag-phase was significantly shorter in patients with insulin-dependent, non-insulin-dependent diabetes mellitus, abdominal obesity and familial hypertriglyceridemic patients than in gluteal-femoral obese subjects and controls (p < 0.01). The shortest lag-phase was found in familial hypertriglyceridemic patients while intermediate values were found in insulin-dependent, non-insulin-dependent and abdominal obese patients who had only a slight increase in triglyceride values. Similarly the lowest value of the LDL cholesterol to protein ratio, as expression of LDL particle size, was found in familial hypertriglyceridemic patients (p < 0.01), while the patients with insulin-dependent, non-insulin-dependent diabetes mellitus and abdominal obesity had intermediate values. The ratio was found to be directly correlated with the length of the lag-phase (r = 0.87, p < 0.001). In spite of similar triglyceride and cholesterol to protein ratio values, however, the length of the lag-phase was significantly shorter in patients with insulin-dependent diabetes mellitus than in those with abdominal obesity. So it is concluded that the different susceptibility to oxidation found in the different groups of patients is only partially explained by plasma triglyceride values.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7648791

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  3 in total

1.  Increased levels of plasma ELAM-1, ICAM-1 and VCAM-1 in NIDDM: possible role of oxidized LDL.

Authors:  L Cominacini; U Garbin; A Fratta Pasini; V Lo Cascio
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

2.  Reduced progression of atherosclerosis in apolipoprotein E-deficient mice treated with lacidipine is associated with a decreased susceptibility of low-density lipoprotein to oxidation.

Authors:  Patrizia Cristofori; Federica Crivellente; Mario Campagnola; Anna Fratta Pasini; Ulisse Garbin; Anna Rigoni; Maria Tosetti; John Turton; Ivo Faustinelli; Luciano Cominacini
Journal:  Int J Exp Pathol       Date:  2004-04       Impact factor: 1.925

3.  Effects of patient-tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low-density lipoprotein cholesterol in patients with type 2 diabetes.

Authors:  Jang Won Son; Dong Jun Kim; Chang Beom Lee; Seungjoon Oh; Kee-Ho Song; Chan Hee Jung; Ji Oh Mok; Jong Hwa Kim; Min Kyong Moon; Kyung Mook Choi; Jae Hyoung Cho; Sung Hee Choi; Soo Kyung Kim; Kang Seo Park; Hye Soon Kim; In Joo Kim; Young Il Kim; Hae Jin Kim; Sang Yong Kim; Sungrae Kim
Journal:  J Diabetes Investig       Date:  2013-03-26       Impact factor: 4.232

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.